/ Pfizer


Pfizer Shares Gain Amid Reports of Deal with the US Government
/ Market Analysis

Pfizer Shares Gain Amid Reports of Deal with the US Government

Pfizer stock climbed over 3% on news of an impending drug-pricing deal with the Trump administration.

September 30, 2025
MTSR Shares Jump After Pfizer Merger Agreement

MTSR Shares Jump After Pfizer Merger Agreement

Metsera stock skyrocketed 62% as Pfizer struck a $4.9 billion acquisition agreement focused on obesity therapies.

September 22, 2025
3 Value Stocks Worth Buying in Current Market Conditions

3 Value Stocks Worth Buying in Current Market Conditions

Big Pharma, Big Tech and REIT is on the value menu. Discount opportunities at this level are rare.

April 01, 2025
Pfizer Targets Up to $64B Revenue in 2025 Amid Strategic Cost Savings

Pfizer Targets Up to $64B Revenue in 2025 Amid Strategic Cost Savings

Pfizer projects 2025 revenues between $61 billion and $64 billion, with a focus on cost savings and strategic initiatives to drive growth.

December 17, 2024
Starboard Value Reportedly Acquires $1B Stake in Pfizer as Stock Lags S&P 500 by 46%

Starboard Value Reportedly Acquires $1B Stake in Pfizer as Stock Lags S&P 500 by 46%

Activist investor Starboard Value has reportedly taken a $1 billion stake in pharmaceutical giant Pfizer.

October 07, 2024

Get Trade Ideas and Market Insights Delivered to You Premarket - Every Day

X